R&D
Trial complexity is the new normal
When operationalised effectively, RBQM can support earlier risk detection and more targeted quality improvement.
Sales & Marketing
Pharma's engagement problem: Are we expecting too much from ...
The question is no longer simply how to attract healthcare professionals to an event. The bigger challenge is how to create meaningful engagement.
Oncology
How today’s biotechs are helping us Stand Up To Cancer
In recognition of Stand Up To Cancer Day, a look at next-generation treatments that are on the verge of making it into clinical practice.
R&D
Mosquitoes, malaria, and UK R&D viral disease vaccine invest...
The UK must sustain investment in malaria R&D as it faces a “perfect storm” of challenges, including mosquito resistance to existing tools.
Market Access
Pharma’s most expensive question is the last one asked
Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
Sales & Marketing
Digital
Market Access
Editor's Picks
Editor's Picks
